SCHEMBL2298328

SCHEMBL2298328

CC(C)(C)c1cc(CO)cc(C(C)(C)C)c1[O]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.44
TSHR P16473 4/20 0.44
MAPK1 P28482 3/20 0.44
CYP1A2 P05177 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
LMNA P02545 3/20 0.44
CYP3A4 P08684 2/20 0.44
BLM P54132 2/20 0.44
ATM Q13315 2/20 0.44
HIF1A Q16665 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
ALOX15 P16050 2/20 0.44
GMNN O75496 1/20 0.44
GABBR2 O75899 1/20 0.44
TP53 P04637 1/20 0.44
CYP2C9 P11712 1/20 0.44
NFKB1 P19838 1/20 0.44
CYP2C19 P33261 1/20 0.44
PMP22 Q01453 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL42656 0.81 ALDH1A1 (0.64) ALDH1A1TSHRMAPK1CYP1A2MEN1
SCHEMBL8514613 0.80 HSPA5 (0.41) ALDH1A1TSHRMAPK1CYP1A2MEN1
SCHEMBL27647600 0.79 ALDH1A1 (0.42) ALDH1A1TSHRMAPK1CYP1A2MEN1
SCHEMBL24114958 0.79 ALDH1A1 (0.41) ALDH1A1TSHRMAPK1CYP1A2MEN1
SCHEMBL2177579 0.78 HSPA5 (0.53) ALDH1A1TSHRMAPK1CYP1A2MEN1
Alcohol SCHEMBL9286265 0.77 ALDH1A1 (0.60) ALDH1A1TSHRMAPK1CYP1A2MEN1
Boric Acid SCHEMBL28025581 0.76 ALDH1A1 (0.58) ALDH1A1TSHRMAPK1CYP1A2MEN1
SCHEMBL18476024 0.76 MAPT (0.47) ALDH1A1TSHRMAPK1CYP1A2MEN1
SCHEMBL10822034 0.76 HSPA5 (0.66) ALDH1A1TSHRMAPK1CYP1A2MEN1
SCHEMBL8572706 0.74 ALDH1A1 (0.42) ALDH1A1TSHRMAPK1CYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2258397-B1 POLYMER CONJUGATE OF PHYSIOLOGICALLY ACTIVE SUBSTANCE NIPPON KAYAKU KK (JP) 2017-10-11 EP disclosed
US-8920788-B2 High-molecular weight conjugate of physiologically active substances NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2014-12-30 US disclosed
US-20110201754-A1 High-Molecular Weight Conjugate Of Physiologically Active Substances NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-08-18 US disclosed
EP-2258397-A1 POLYMER CONJUGATE OF PHYSIOLOGICALLY ACTIVE SUBSTANCE Nippon Kayaku Kabushiki Kaisha (JP) 2010-12-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201754-A1 High-Molecular Weight Conjugate Of Physiologically Active Substances OGFR, ACP1, FCGR2A ALDH1A1 618/4885TSHR 284/4885MAPK1 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.